Spruce Biosciences, Inc. (SPRB)
NASDAQ: SPRB · Real-Time Price · USD
43.31
+0.42 (0.98%)
At close: Nov 13, 2026, 4:00 PM EST
43.12
-0.19 (-0.44%)
After-hours: Nov 13, 2026, 7:30 PM EST
Spruce Biosciences Revenue
Revenue (ttm)
n/a
Revenue Growth
n/a
P/S Ratio
n/a
Revenue / Employee
n/a
Employees
25
Market Cap
124.47M
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | - | - | - |
| Dec 31, 2024 | 4.91M | -5.18M | -51.32% |
| Dec 31, 2023 | 10.09M | - | - |
| Dec 31, 2022 | - | - | - |
| Dec 31, 2021 | - | - | - |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. It does not take any expenses into account and is therefore different from profits.
Related Stocks
| Company Name | Revenue |
|---|---|
| Foghorn Therapeutics | 112.13M |
| Codexis | 88.34M |
| Abeona Therapeutics | 39.01M |
| LENZ Therapeutics | 12.36M |
| Adagene | 9.29M |
| Molecular Partners AG | 856.30K |
SPRB News
- 5 days ago - Spruce Biosciences Transcript: 3rd Annual Guggenheim Healthcare Innovation Conference - Transcripts
- 6 days ago - Spruce Biosciences reports Q3 EPS ($8.51), consensus ($5.51) - TheFly
- 6 days ago - Spruce Biosciences sees cash runway into 2H27 - TheFly
- 6 days ago - Spruce Biosciences Reports Third Quarter 2026 Financial Results and Provides Corporate Updates - Business Wire
- 6 days ago - Spruce Biosciences Earnings release: Q3 2026 - Filings
- 6 days ago - Spruce Biosciences Quarterly report: Q3 2026 - Filings
- 6 days ago - Spruce Biosciences separates CRHX-101 program into Adrenyx Biosciences - TheFly
- 6 days ago - Spruce Biosciences Announces Separation of CRHX-101 (Formerly SPR-202) Program into Adrenyx Biosciences - Business Wire